MyAverix Finance
F · Healthcare
ONCODES.PREC.MED. EO-34 (ZR8)
Biotechnology
ONCODES.PREC.MED. EO-34 (ZR8) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZR8
ONCODES.PREC.MED. EO-34 (ZR8) — FAQ
What is ZR8's P/E ratio?
The price-to-earnings (P/E) ratio for ONCODES.PREC.MED. EO-34 (ZR8) is 25.00 (data as of 2026-05-23).
Does ONCODES.PREC.MED. EO-34 pay a dividend?
Dividend yield is not available in the current snapshot for ONCODES.PREC.MED. EO-34 (ZR8). Check the MyAverix Finance app for the latest dividend data.
What sector is ONCODES.PREC.MED. EO-34 in?
ONCODES.PREC.MED. EO-34 (ZR8) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ZR8 listed on?
ZR8 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.